2017 FDA Peptide Harvest
File(s)pharmaceuticals-11-00042.pdf (1.84 MB)
Published version
OA Location
Author(s)
Al Musaimi, Othman
Al Shaer, Danah
de la Torre, Beatriz G
Albericio, Fernando
Type
Journal Article
Abstract
2017 was an excellent year in terms of new drugs (chemical entities and biologics) approved by the FDA, with a total of 46. In turn, one of the highlights was the number of peptides (six) included in this list. Here, the six peptides are analyzed in terms of chemical structure, synthetic strategy used for their production, source, therapeutic use, and mode of action.
Date Issued
2018-06-01
Date Acceptance
2018-05-03
Citation
Pharmaceuticals, 2018, 11 (2), pp.1-10
ISSN
1424-8247
Publisher
MDPI AG
Start Page
1
End Page
10
Journal / Book Title
Pharmaceuticals
Volume
11
Issue
2
Copyright Statement
© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/)
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/)
License URL
Identifier
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000445152300012&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
Subjects
Science & Technology
Life Sciences & Biomedicine
Chemistry, Medicinal
Pharmacology & Pharmacy
pharmaceutical market
drugs
drug discovery
solid-phase peptide synthesis
CALCIUM-SENSING RECEPTOR
SERUM PARATHYROID-HORMONE
AMG 416
SECONDARY HYPERPARATHYROIDISM
AGONIST
ETELCALCETIDE
DISCOVERY
PHARMACOKINETICS
HEMODIALYSIS
PLECANATIDE
Publication Status
Published
Article Number
ARTN 42
Date Publish Online
2018-05-07